Interpace Diagnostics competitive analysis

Loading summary...

Explore Interpace Diagnostics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 29, 2017Mirnas As Biomarkers For Distinguishing Benign From Malignant Thyroid Neoplasms1

Latest publications and patents of Interpace Diagnostics New

Explore the latest publications and patents granted to Interpace Diagnostics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Interpace Diagnostics

Mar 29, 2017Mirnas As Biomarkers For Distinguishing Benign From Malignant Thyroid NeoplasmsRevoked

Latest PTAB cases involving Interpace Diagnostics

Discover the latest PTAB cases involving Interpace Diagnostics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Interpace Diagnostics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERPACE DIAGNOSTICS - 1 - -
URQUHART DYKES & LORD1 - - -